BRITAIN: Justin Gover does not look like a drug dealer. But he is, albeit a legal one. Neither does he look much like a hero. But he could well become one to the 100,000 people who suffer from multiple sclerosis in Britain after producing a medicine that has been shown to relieve the pain associated with the disease.
The discovery may also put an end to MS sufferers’ widespread dependence on cannabis which many have used for decades to alleviate symptoms of the disorder.
In June, GW Pharmaceuticals, at which Gover is managing director, launched Sativex in the UK.
It was a world first – the only cannabis-based treatment to get a green light from medical authorities for use as a prescription drug.
*
*
***********************************************************
“Providing You with ‘MS Views and News’, is what we do“
Keep Informed and up–to–date with information concerning
Multiple Sclerosis when registered at
the MS Views and News website.
(This will take 20-25 seconds and will empower you
with informaton and learning)
Thank you for allowing me to help to keep you informed
****************************************************************
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews